{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:42:35Z","timestamp":1760985755670},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T00:00:00Z","timestamp":1536019200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1245\/s10434-018-6741-x","type":"journal-article","created":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T14:55:29Z","timestamp":1536072929000},"page":"3613-3620","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors"],"prefix":"10.1245","volume":"25","author":[{"given":"David","family":"Strosberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric B.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Onesti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhavana","family":"Konda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manisha","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Dillhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl R.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence A.","family":"Shirley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,4]]},"reference":[{"issue":"6","key":"6741_CR1","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3109\/02841868709113712","volume":"26","author":"K Oberg","year":"1987","unstructured":"Oberg K, Norheim I, Lundqvist G, Wide L. Cytotoxic treatment in patients with malignant carcinoid tumors. Response to streptozocin\u2013alone or in combination with 5-FU. Acta Oncol. (Stockholm, Sweden). 1987;26(6):429\u201332.","journal-title":"Acta Oncol Stockholm, Sweden."},{"issue":"6","key":"6741_CR2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0936-6555(97)80132-X","volume":"9","author":"MQ Hatton","year":"1997","unstructured":"Hatton MQ, Reed NS. Chemotherapy for neuroendocrine tumors: the Beatson Oncology Centre experience. Clin Oncol [Royal College of Radiologists (Great Britain)]. 1997;9(6):385\u20139.","journal-title":"Clin Oncol Royal College of Radiologists Great Britain."},{"issue":"14","key":"6741_CR3","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1200\/JCO.2003.12.142","volume":"21","author":"S Faiss","year":"2003","unstructured":"Faiss S, Pape UF, Bohmig M, et al. Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors\u2013the International Lanreotide and Interferon Alfa Study Group. J Clin Oncol. 2003;21(14):2689\u201396.","journal-title":"J Clin Oncol."},{"issue":"7","key":"6741_CR4","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/sj.bjc.6605618","volume":"102","author":"NC Turner","year":"2010","unstructured":"Turner NC, Strauss SJ, Sarker D, et al. Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours. Br J Cancer. 2010;102(7):1106\u201312.","journal-title":"Br J Cancer."},{"issue":"8","key":"6741_CR5","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1002\/1097-0142(19930415)71:8<2624::AID-CNCR2820710830>3.0.CO;2-B","volume":"71","author":"P Ruszniewski","year":"1993","unstructured":"Ruszniewski P, Rougier P, Roche A, et al. Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients. Cancer. 1993;71(8):2624\u201330.","journal-title":"Cancer."},{"issue":"5","key":"6741_CR6","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/S0002-9610(98)00042-7","volume":"175","author":"JG Drougas","year":"1998","unstructured":"Drougas JG, Anthony LB, Blair TK, et al. Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors. Am J Surg. 1998;175(5):408\u201312.","journal-title":"Am J Surg."},{"issue":"1","key":"6741_CR7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s00330-002-1558-0","volume":"13","author":"A Roche","year":"2003","unstructured":"Roche A, Girish BV, de Baere T, et al. Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors. Eur Radiol. 2003;13(1):136\u201340.","journal-title":"Eur Radiol."},{"issue":"8","key":"6741_CR8","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1002\/cncr.21389","volume":"104","author":"S Gupta","year":"2005","unstructured":"Gupta S, Johnson MM, Murthy R, et al. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival. Cancer. 2005;104(8):1590\u2013602.","journal-title":"Cancer."},{"issue":"3","key":"6741_CR9","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s11605-007-0089-z","volume":"11","author":"M Bloomston","year":"2007","unstructured":"Bloomston M, Al-Saif O, Klemanski D, et al. Hepatic artery chemoembolization in 122 patients with metastatic carcinoid tumor: lessons learned. J Gastrointest Surg. 2007;11(3):264\u201371.","journal-title":"J Gastrointest Surg."},{"issue":"1","key":"6741_CR10","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1177\/107327480601300110","volume":"13","author":"JR Strosberg","year":"2006","unstructured":"Strosberg JR, Choi J, Cantor AB, Kvols LK. Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors. Cancer Control. 2006;13(1):72\u20138.","journal-title":"Cancer Control."},{"issue":"3","key":"6741_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0167-0115(00)00167-1","volume":"96","author":"DC Desai","year":"2001","unstructured":"Desai DC, O\u2019Dorisio TM, Schirmer WJ, Jung SS, Khabiri H, Villanueva V, Martin EW. Serum pancreastatin levels predict response to hepatic artery chemoembolization and somatostatin analogue therapy in metastatic neuroendocrine tumors. Regulatory Peptides. 2001;96(3):113\u20137.","journal-title":"Regulatory Peptides."},{"issue":"4","key":"6741_CR12","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1245\/s10434-012-2786-4","volume":"20","author":"D Arrese","year":"2013","unstructured":"Arrese D, McNally ME, Chokshi R, et al. Extrahepatic disease should not preclude transarterial chemoembolization for metastatic neuroendocrine carcinoma. Ann Surg Oncol. 2013;20(4):1114\u20131120.","journal-title":"Ann Surg Oncol."},{"issue":"5","key":"6741_CR13","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/MPA.0b013e3181c68d7a","volume":"39","author":"TM O\u2019Dorisio","year":"2010","unstructured":"O\u2019Dorisio TM, Krutzik SR, Woltering EA, et al. Development of a highly sensitive and specific carboxy-terminal human pancreastatin assay to monitor neuroendocrine tumor behavior. Pancreas. 2010;39(5):611\u20136.","journal-title":"Pancreas."},{"issue":"7","key":"6741_CR14","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1097\/MPA.0000000000000572","volume":"45","author":"TM Khan","year":"2016","unstructured":"Khan TM, Garg M, Warner RR, Uhr JH, Divino CM. Elevated serum pancreastatin is an indicator of hepatic metastasis in patients with small bowel neuroendocrine tumors. Pancreas. 2016;45(7):1032\u20135.","journal-title":"Pancreas."},{"issue":"4","key":"6741_CR15","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.jamcollsurg.2015.12.014","volume":"222","author":"EA Woltering","year":"2016","unstructured":"Woltering EA, Beyer DT, Thiagarajan R, Ramirez RA, Wang YZ, Ricks MJ, Boudreaux JP. Elevated plasma pancreastatin, but not chromogranin a, predicts survival in neuroendocrine tumors of the duodenum. J Am Coll Surg. 2016;222(4):534\u201342.","journal-title":"J Am Coll Surg."},{"issue":"9","key":"6741_CR16","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1245\/s10434-014-3728-0","volume":"21","author":"SK Sherman","year":"2014","unstructured":"Sherman SK, Maxwell JE, O\u2019Dorisio MS, O\u2019Dorisio TM, Howe JR. Pancreastatin predicts survival in neuroendocrine tumors. Ann Surg Oncol. 2014;21(9):2971\u201380.","journal-title":"Ann Surg Oncol."},{"issue":"Suppl 1","key":"6741_CR17","doi-asserted-by":"publisher","first-page":"S286","DOI":"10.1007\/s12032-010-9750-6","volume":"28","author":"XD Dong","year":"2011","unstructured":"Dong XD, Carr BI. Hepatic artery chemoembolization for the treatment of liver metastases from neuroendocrine tumors: a long-term follow-up in 123 patients. Med Oncol (Northwood, London, England). 2011;28 Suppl 1:S286\u201390.","journal-title":"Med Oncol Northwood, London, England."},{"issue":"5","key":"6741_CR18","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.2214\/AJR.06.0933","volume":"188","author":"AS Ho","year":"2007","unstructured":"Ho AS, Picus J, Darcy MD, Tan B, Gould JE, Pilgram TK, Brown DB. Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors. AJR Am J Roentgenol. 2007;188(5):1201\u20137.","journal-title":"AJR Am J Roentgenol."},{"issue":"2","key":"6741_CR19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/MPA.0000000000000030","volume":"43","author":"ES Engelman","year":"2014","unstructured":"Engelman ES, Leon-Ferre R, Naraev BG, et al. Comparison of transarterial liver-directed therapies for low-grade metastatic neuroendocrine tumors in a single institution. Pancreas. 2014;43(2):219\u201325.","journal-title":"Pancreas."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-018-6741-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-6741-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-6741-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T22:14:08Z","timestamp":1604873648000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-018-6741-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,4]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["6741"],"URL":"https:\/\/doi.org\/10.1245\/s10434-018-6741-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,4]]},"assertion":[{"value":"11 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No authors have any commercial interest in the subject of study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}